# Real World Data on Ibrutinib Use in PCNSL Rel/Ref

> **NCT05782374** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 36 (estimated)

## Conditions studied

- PCNSL

## Interventions

- **DRUG:** Ibrutinib

## Key facts

- **NCT ID:** NCT05782374
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-10
- **Primary completion:** 2023-01-10
- **Final completion:** 2026-08-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05782374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05782374, "Real World Data on Ibrutinib Use in PCNSL Rel/Ref". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05782374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*